New York, NY -- (SBWire) -- 12/22/2021 --Severe spinal cord injuries can be some of the hardest to treat and offer the most difficult path to recovery. Now, the discovery of 'dancing molecules' may provide hope to those who have suffered a devastating spinal cord injury, as they may be able to reverse paralysis and repair tissues. In a new study, paralyzed mice were injected with just one dose of a new therapy - and a month later regained the ability to walk. The treatment sends bioactive signals to trigger cells to repair and regenerate. It works in a number of key ways, including diminishing scar tissue, which can be a barrier to repair, and assisting the formation of functional blood vessels to deliver nutrients to cells at the injury site. The goal of the research has been to find a therapy that would mean individuals who are paralyzed don't have to remain that way permanently, whether that is the result of disease or major trauma.

R&D jobs in pharma is just one area where EPM Scientific is able to provide expert support to life sciences organizations keen to recruit the next generation of innovative minds. The firm was established in 2012 and has grown alongside the life sciences sector, expanding into many different fields, including hiring for legal and compliance, clinical development, regulatory roles, medical communications, medical affairs and quality. With such a broad spectrum of expertise the firm has been able to work with many different organizations in life sciences, from innovative start-ups to large, global brands. With a database of more than a million mid-to-senior professionals, the firm is able to secure business-critical talent for vital areas, such as R&D jobs in pharma. A combination of permanent, contract and multi-hire solutions ensures that options are available for every situation.

EPM Scientific has extensive experience in recruiting for the life sciences sector and is a go to for talented people in areas such as R&D jobs in pharma looking to take career-defining next steps. The firm is able to provide nationwide support that covers all major cities, including New York, Chicago, Boston, Dallas, Charlotte, Los Angeles and San Francisco. This widespread USA-based coverage is complemented by the fact that the team is part of a 1,000+ strong worldwide workforce. The firm is also in the enviable position of being the recruitment partner of choice to hundreds of world-leading companies through being part of the Phaidon International group, which operates across 6 countries. EPM Scientific recognizes how vital internal teams are to growth and invests heavily in its own people. Consultants receive training on an ongoing basis and work with best-in-class recruitment technology and strategies. As well as R&D jobs in pharma there are many other roles available via the firm today, including Senior Research Associate, Medical Director and Senior Integration Scientist/Engineer.

"Like for many sectors, 2020 marked a defining moment for recruitment. Challenged by uncertainty, but unwavering in our commitment to our clients, we have endured through 2021 with a sense of duty to clients and candidates", commented Kieran Behan, Managing Director at EPM Scientific. He went on to say, "as we reflect on the challenges of virtually securing and retaining talent, we're inspired by a team who have demonstrated a remarkable ability to adapt and continue to help all our clients secure top talent on a global scale."

To find out more about R & D Jobs in Pharma visit https://www.epmscientific.com.

For any media inquiries please contact Gary Elliott at Iconic Digital – 020 7100 0726.

For all other inquiries please contact EPM Scientific USA: +1 646 759 4560.

For more information about EPM Scientific services, please go to https://www.epmscientific.com.

About EPM Scientific USA
EPM Scientific USA partners with organizations across the fast-expanding pharmacovigilance sector. The firm's 1000+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.